Treatment with the antibiotic azithromycin reduces abnormal thickening of the walls of bronchi — air passages leading to the…
Articles by Margarida Maia, PhD
Treatment with Kaftrio (elexacaftor, tezacaftor, and ivacaftor), sold as Trikafta in the U.S., may save people with cystic…
Highly effective CFTR modulators, which target the cause of cystic fibrosis (CF), may ease signs of low iron levels…
Abnormal glucose tolerance is common in young cystic fibrosis (CF) patients. Early screening, starting at the age of 5,…
The Cystic Fibrosis Foundation (CFF) has invested another $5 million into BiomX, which will help fund a Phase…
Sotagliflozin, an oral medication approved in the U.S. under the brand name Inpefa as a broadly used treatment for…
Some people with cystic fibrosis (CF) have levels of sweat chloride above the cut-off for a diagnosis of the…
BiomX and Adaptive Phage Therapeutics (APT) are entering into a merger agreement with a goal of pooling resources to advance…
The Cystic Fibrosis Foundation (CFF) is encouraging individuals and nonprofits to apply by April 5 for one of its…
In children with cystic fibrosis (CF) treated with Orkambi (ivacaftor/lumacaftor), the levels of the medication reached in the blood depend…